Press "Enter" to skip to content

MTIP AG | MTIP Announces Strong First Closing of Fund II to drive Healthtech Innovation

Today, MTIP AG, a Basel-based personal fairness agency that invests in healthtech corporations, is happy to announce that it has accomplished the primary closing of its Fund II. The development capital fund secured EUR 130m and is effectively on monitor in direction of the goal fund dimension of EUR 200m.

MTIP FUND II, SCSp is MTIP’s second healthtech fund, designed to offer development capital and construct on the healthtech funding thesis of its profitable predecessor. With a goal dimension of EUR 200m the fund invests in digital well being and related medical machine corporations, based mostly primarily in Europe, that provide differentiated options for a quickly evolving healthcare atmosphere.

MTIP

MTIP

MTIP’s second fund executed a robust first closing securing EUR 130m. The capital was raised by totally different traders comprising primarily institutional traders, pension funds, household places of work, hospitals, and foundations. The firm is proud to work along with the European Investment Fund (EIF) as an anchor investor. EIF’s Chief Executive Alain Godard stated: “MTIP’s fund strategy fits with EIF’s ambition of financing the vital growth segment of the European Venture Capital ecosystem, which is largely underfunded and overly dependent on non-European investors for larger investments. The EIF is pleased to support MTIP and tackle two major gaps in the European market – digital health and growth capital.”

“This closing is an enormously important milestone in our company history, and we are pleased to have overachieved our expectations. Our Fund II has already added three stellar investments in Oviva, Trialbee and Koa Health to its portfolio with more to come soon. This creates a strong momentum towards the final close”, emphasizes Dr. Christoph Kausch, Managing Partner of MTIP. The Fund continues to see a novel stream of funding alternatives, enhanced by the agency’s community, its main function in Europe, and the power of its technique.

For extra Information please contact:
Dr. Christoph Kausch, Managing Partner
E-Mail: communications@mtip.ch

ABOUT MTIP
MTIP is a fast-growing pan-European healthtech development capital investor, based mostly in Basel Switzerland. We spend money on digital well being and digitally related medical machine corporations, with choices that present clear health-related financial advantages. Our entrepreneurial funding crew, which has complementary personal fairness expertise and distinctive deal-making capabilities, actively works with our portfolio corporations to spice up development. MTIP effectively deploys capital to unlock worth and generate enticing returns for our traders. Visit www.mtip.ch for extra data

Be First to Comment

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    %d bloggers like this: